Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide
about
Crystal structure of HLA-DP2 and implications for chronic beryllium diseaseMapping the HLA-DO/HLA-DM complex by FRET and mutagenesisSimilar antigenic surfaces, rather than sequence homology, dictate T-cell epitope molecular mimicryStructural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac diseaseCrystal structure of staphylococcal enterotoxin I (SEI) in complex with a human major histocompatibility complex class II moleculeStructure of a complex of the human alpha/beta T cell receptor (TCR) HA1.7, influenza hemagglutinin peptide, and major histocompatibility complex class II molecule, HLA-DR4 (DRA*0101 and DRB1*0401): insight into TCR cross-restriction and alloreactivHLA DRB4 0101-restricted immunodominant T cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune diseasesTypes of inter-atomic interactions at the MHC-peptide interface: identifying commonality from accumulated dataMULTIPRED: a computational system for prediction of promiscuous HLA binding peptides.A step-by-step overview of the dynamic process of epitope selection by major histocompatibility complex class II for presentation to helper T cellsMachine Learning Methods for Predicting HLA-Peptide Binding ActivityStructural basis of metal hypersensitivityImmunological barriers to stem cell therapy in the central nervous systemCrystal structure of the HLA-Cw3 allotype-specific killer cell inhibitory receptor KIR2DL2Structure of a covalently stabilized complex of a human alphabeta T-cell receptor, influenza HA peptide and MHC class II molecule, HLA-DR1Structure of a human insulin peptide-HLA-DQ8 complex and susceptibility to type 1 diabetesCrystal structure of a superantigen bound to MHC class II displays zinc and peptide dependenceStructural Basis of Cytochrome c Presentation by IE kAlternate interactions define the binding of peptides to the MHC molecule IA(b).Exploration of the P6/P7 region of the peptide-binding site of the human class II major histocompatability complex protein HLA-DR1Crystal Structure of Mycoplasma arthritidis Mitogen Complexed with HLA-DR1 Reveals a Novel Superantigen Fold and a Dimerized Superantigen-MHC ComplexFluorogenic probes for monitoring peptide binding to class II MHC proteins in living cellsStructural basis for the presentation of tumor-associated MHC class II-restricted phosphopeptides to CD4+ T cellsAnti-Group A Streptococcal Vaccine Epitope: STRUCTURE, STABILITY, AND ITS ABILITY TO INTERACT WITH HLA CLASS II MOLECULESMinimal conformational plasticity enables TCR cross-reactivity to different MHC class II heterodimersCrystal Structure of the HLA-DM–HLA-DR1 Complex Defines Mechanisms for Rapid Peptide SelectionDisruption of Hydrogen Bonds between Major Histocompatibility Complex Class II and the Peptide N-Terminus Is Not Sufficient to Form a Human Leukocyte Antigen-DM Receptive State of Major Histocompatibility Complex Class IIMolecular Basis of a Dominant T Cell Response to an HIV Reverse Transcriptase 8-mer Epitope Presented by the Protective Allele HLA-B*51:01MR1 presents microbial vitamin B metabolites to MAIT cellsSusceptibility to HLA-DM Protein Is Determined by a Dynamic Conformation of Major Histocompatibility Complex Class II Molecule Bound with PeptideHigh-resolution crystal structures of tyrosine kinase SH3 domains complexed with proline-rich peptidesDifferential thymic selection outcomes stimulated by focal structural alteration in peptide/major histocompatibility complex ligandsCrystal structure of HLA-DR2 (DRA*0101, DRB1*1501) complexed with a peptide from human myelin basic proteinRecognition of peroxisomal targeting signal type 1 by the import receptor Pex5p.Genetic influences on sarcoidosisAssociation between the HLA-DRB1 gene and clinical features of systemic sclerosis in KoreaThe rsp5-domain is shared by proteins of diverse functionsHuman leukocyte antigen class II haplotypes affect clinical characteristics and progression of type 1 autoimmune hepatitis in JapanPeptide binding to HLA-DP proteins at pH 5.0 and pH 7.0: a quantitative molecular docking studyPredicting Hemagglutinin MHC-II Ligand Analogues in Anti-TNFα Biologics: Implications for Immunogenicity of Pharmaceutical Proteins
P2860
Q24305214-B5C23BD2-93CD-499B-A190-F4F61D702010Q24338938-D1CB2766-92AC-492B-B3F8-A73994FAAB22Q24563454-7B565DBF-F39D-4473-A077-97E7ABCC2C40Q24633885-B6970A28-ACAC-4699-9218-8F534253C8F0Q24648495-7CB965D7-BEAC-4E34-AEBB-419C0DF3CD12Q24673986-D84D6FD8-F64D-479E-A819-BD83AFAF7030Q24679388-1AE8F733-AAEF-459F-ACE3-732BEFF5C125Q24793027-C5592F79-B743-41B9-9580-46B04C3297BEQ24813031-C1EB5031-BB42-403F-A748-749A6C3F3725Q26747063-1781F8B2-2E4D-4C29-B116-C3CB689291CCQ26778112-CC3F7AE9-86A0-4D2C-B1EB-3095BD611E3FQ26853141-AA06F15C-E8D0-42AB-AD82-3E4689602EFBQ27027960-9B7750C8-7E2D-404C-B32A-A23F7556F5E8Q27617783-98FF9C80-D96F-4AD9-AC04-473A3D80469AQ27627794-FF39293F-BC6D-4ED9-BAE7-710E181C0BB7Q27632133-7AA0DF3C-1990-44E0-80AE-2093231C7D73Q27632891-82C03CC6-7C18-4FF5-929F-4F123F11382BQ27638866-838C671F-3609-43AF-8120-9AD060EAEA7FQ27639260-E91D84E7-5C8F-48C4-BF19-DA2AAE5C998EQ27641946-11D5E527-C964-4723-B9AE-0AFD1FD9901BQ27643132-28D5E8CF-E0D5-4759-9BFE-1C26B5912167Q27644030-9B15C90D-68ED-4B64-9189-151760B705E0Q27660843-18622B1B-D674-4EF8-8ACE-35E21242E41BQ27666345-4597D5F5-4D4D-46A1-8E90-AB0244038EB2Q27672472-682857DF-DA8C-45C3-967E-D687E537A19EQ27675568-5F7D118C-882D-4818-9052-8AD47630F8D7Q27679799-87A91A29-73BD-4875-8C54-4518ABF1B4BEQ27682033-078C0A0E-1F37-46BD-8D28-3483951EEF6BQ27682747-183EF4FA-54E2-4BF2-82DE-8FF2044FD8BFQ27684590-CA6DD3DD-071E-44E1-B11D-8DE018915DEAQ27729869-97ED8446-E0B0-49E7-8A05-96832537163EQ27765141-4618138D-4727-49A5-A1EB-55761C551038Q27765717-07D6F548-22FC-4F50-A3C4-EAE781A212D2Q27937596-EC11C8CF-07E5-4EBD-BE89-62A653B0552FQ28253017-EACE9A8E-E5F1-43DD-B104-0E0BFC3ED92AQ28296258-0B7694EE-185C-4329-8FF3-F751B9682A94Q28305776-E4684053-1E66-4400-BBCC-8EB06379A886Q28388529-10DD9740-A6CD-4CDE-AF91-AF1635225ED3Q28391460-16BEEA57-9BDA-4748-8AB4-7F0ED4746A04Q28547255-DDEB9990-18C2-4501-828F-408CC325EC99
P2860
Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide
description
1994 nî lūn-bûn
@nan
1994 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի մարտին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Crystal structure of the human ...... ith an influenza virus peptide
@ast
Crystal structure of the human ...... ith an influenza virus peptide
@en
Crystal structure of the human ...... ith an influenza virus peptide
@nl
type
label
Crystal structure of the human ...... ith an influenza virus peptide
@ast
Crystal structure of the human ...... ith an influenza virus peptide
@en
Crystal structure of the human ...... ith an influenza virus peptide
@nl
prefLabel
Crystal structure of the human ...... ith an influenza virus peptide
@ast
Crystal structure of the human ...... ith an influenza virus peptide
@en
Crystal structure of the human ...... ith an influenza virus peptide
@nl
P2093
P3181
P356
P1433
P1476
Crystal structure of the human ...... ith an influenza virus peptide
@en
P2093
P2888
P304
P3181
P356
10.1038/368215A0
P407
P577
1994-03-17T00:00:00Z
P6179
1000873113